NANOVIRICIDES, INC. (NNVC)

↓ Download CSV

CIK 0001379006 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

In fiscal 2025, NANOVIRICIDES, INC. reported revenue of $0. The company ran a net loss. It held $8.82M in total assets against $1.30M in total liabilities.

Key ratios (FY2025)

-125.9%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$0$0$0
Operating Income-$9.59M-$8.52M-$8.94M-$8.11M-$8.74M-$8.00M-$8.66M-$9.33M-$9.60M-$8.86M
Net Income-$9.47M-$8.29M-$8.59M-$8.11M-$8.82M-$13.45M-$8.42M-$8.56M-$10.30M-$10.72M
EPS (Diluted)$-0.63$-0.70$-0.74$-0.70$-0.81$-0.13$-0.17$-0.19
Total Assets$8.82M$12.82M$16.90M$23.49M$30.26M$23.91M$13.45M$18.55M$27.00M$36.63M
Total Liabilities$1.30M$1.36M$2.03M$412.8K$881.9K$6.68M$13.59M
Shareholders' Equity$7.52M$11.46M$14.87M$23.08M$29.91M$21.76M$10.60M$17.66M$20.32M$23.05M
Cash & Equivalents$1.56M$4.80M$8.15M$14.07M$20.52M$13.71M$2.56M$7.08M$15.10M$24.16M
Operating Cash Flow-$8.48M-$6.32M-$5.67M-$5.89M-$8.21M-$6.67M-$6.80M-$7.78M-$7.90M-$6.83M
Capital Expenditures$57.0K$156.6K$151.7K$324.3K$238.8K$8.6K$73.8K$241.8K$165.0K$476.4K
Shares Outstanding16.61M13.14M11.70M11.59M11.52M9.08M3.84M69.17M63.31M58.18M